Amanda Yu

1.8k total citations
67 papers, 1.3k citations indexed

About

Amanda Yu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Amanda Yu has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 50 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Amanda Yu's work include Hepatitis C virus research (47 papers), Hepatitis B Virus Studies (35 papers) and Liver Disease Diagnosis and Treatment (34 papers). Amanda Yu is often cited by papers focused on Hepatitis C virus research (47 papers), Hepatitis B Virus Studies (35 papers) and Liver Disease Diagnosis and Treatment (34 papers). Amanda Yu collaborates with scholars based in Canada, United States and Australia. Amanda Yu's co-authors include Mel Krajden, Maria Alvarez, Naveed Z. Janjua, Mark Tyndall, Zahid A Butt, Jason Wong, Stanley Wong, Margot Kuo, Darrel Cook and Jane A. Buxton and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Amanda Yu

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda Yu Canada	22	1.0k	912	177	112	50	67	1.3k
Oluwaseun Falade‐Nwulia United States	20	1.1k 1.1×	1.0k 1.1×	393 2.2×	146 1.3×	51 1.0×	75	1.6k
Mark Sonderup South Africa	18	715 0.7×	671 0.7×	272 1.5×	43 0.4×	39 0.8×	64	1.1k
Andrea Mariano Italy	15	813 0.8×	708 0.8×	170 1.0×	49 0.4×	43 0.9×	34	1.0k
Ivana Carey United Kingdom	21	903 0.9×	843 0.9×	205 1.2×	131 1.2×	61 1.2×	65	1.3k
Jennifer C. Price United States	20	850 0.8×	728 0.8×	185 1.0×	119 1.1×	142 2.8×	89	1.4k
Tracy Swan United States	16	1.2k 1.1×	1.2k 1.4×	341 1.9×	49 0.4×	12 0.2×	31	1.5k
Jennifer H MacLachlan Australia	15	795 0.8×	564 0.6×	214 1.2×	41 0.4×	9 0.2×	42	981
Edward R. Cachay United States	23	1.1k 1.0×	607 0.7×	480 2.7×	64 0.6×	25 0.5×	95	1.5k
Carmine Rossi United States	16	487 0.5×	453 0.5×	194 1.1×	42 0.4×	12 0.2×	85	846
Valerianna Amorosa United States	18	346 0.3×	332 0.4×	375 2.1×	40 0.4×	22 0.4×	36	888

Countries citing papers authored by Amanda Yu

Since Specialization

Citations

This map shows the geographic impact of Amanda Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Yu more than expected).

Fields of papers citing papers by Amanda Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Yu. The network helps show where Amanda Yu may publish in the future.

Co-authorship network of co-authors of Amanda Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Yu. A scholar is included among the top collaborators of Amanda Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Yu. Amanda Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamadeh, Abdullah, Ana Maria Passos‐Castilho, Ayşegül Erman, et al.. (2024). Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver International. 44(6). 1383–1395. 3 indexed citations

Makuza, Jean Damascène, Stanley Wong, Richard L. Morrow, et al.. (2024). Impact of COVID‐19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study. Journal of Viral Hepatitis. 31(10). 592–600. 2 indexed citations

Makuza, Jean Damascène, Dahn Jeong, Stanley Wong, et al.. (2024). Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study. The Lancet Regional Health - Americas. 36. 100826–100826. 2 indexed citations

Morrow, Richard L., Mawuena Binka, Sofia Bartlett, et al.. (2024). Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Viruses. 16(5). 655–655. 2 indexed citations

Adu, Prince, Mawuena Binka, Bushra Mahmood, et al.. (2022). Cohort profile: the British Columbia COVID-19 Population Mixing Patterns Survey (BC-Mix). BMJ Open. 12(8). e056615–e056615. 5 indexed citations

Makuza, Jean Damascène, Dahn Jeong, Mawuena Binka, et al.. (2022). Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study. Viruses. 14(11). 2579–2579. 5 indexed citations

Adu, Prince, Sarafa A. Iyaniwura, Bushra Mahmood, et al.. (2022). Association between close interpersonal contact and vaccine hesitancy: Findings from a population-based survey in Canada. Frontiers in Public Health. 10. 971333–971333.

Darvishian, Maryam, Stanley Wong, Mawuena Binka, et al.. (2022). Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort. Frontiers in Oncology. 12. 983238–983238. 6 indexed citations

Janjua, Naveed Z., Stanley Wong, Dahn Jeong, et al.. (2021). Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. Journal of Hepatology. 75(5). 1049–1057. 38 indexed citations

10.

Wilton, James, Mei Chong, Mohammad Ehsanul Karim, et al.. (2021). Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study. BMJ. 375. e066965–e066965. 17 indexed citations

11.

Wilton, James, Stanley Wong, Amanda Yu, et al.. (2020). Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study. Open Forum Infectious Diseases. 7(3). ofaa055–ofaa055. 26 indexed citations

12.

Janjua, Naveed Z., Stanley Wong, Maryam Darvishian, et al.. (2020). The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk. Journal of Viral Hepatitis. 27(8). 781–793. 37 indexed citations

13.

Bartlett, Sofia, Michael Otterstatter, Jane A. Buxton, et al.. (2020). Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services. International Journal of Infectious Diseases. 100. 27–33. 4 indexed citations

14.

Krajden, Mel, Darrel Cook, Stanley Wong, et al.. (2019). What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada. International Journal of Drug Policy. 72. 114–122. 16 indexed citations

15.

Janjua, Naveed Z., Maryam Darvishian, Stanley Wong, et al.. (2019). Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy. Hepatology Communications. 3(4). 478–492. 22 indexed citations

16.

Darvishian, Maryam, Stanley Wong, Mawuena Binka, et al.. (2019). Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies. Journal of Viral Hepatitis. 27(3). 243–260. 23 indexed citations

17.

Butt, Zahid A, Sunny Mak, Dionne Gesink, et al.. (2018). Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada. Journal of Viral Hepatitis. 26(3). 373–383. 3 indexed citations

18.

Darvishian, Maryam, Naveed Z. Janjua, Mei Chong, et al.. (2018). Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk. Journal of Viral Hepatitis. 25(12). 1481–1492. 8 indexed citations

19.

Islam, Nazrul, Mel Krajden, Jean Shoveller, et al.. (2017). Hepatitis C cross-genotype immunity and implications for vaccine development. Scientific Reports. 7(1). 12326–12326. 12 indexed citations

20.

Janjua, Naveed Z., Margot Kuo, Mei Chong, et al.. (2016). Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants. PLoS ONE. 11(3). e0150176–e0150176. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact